Nail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features

被引:23
|
作者
Rosso Schons, Karen Regina [1 ]
Costa Beber, Andre Avelino [2 ]
Beck, Maristela de Oliveira [2 ]
Monticielo, Odirlei Andre [3 ]
机构
[1] Univ Passo Fundo, Passo Fundo, RS, Brazil
[2] Univ Fed Santa Maria, BR-97119900 Santa Maria, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
关键词
Dermatology; Nails; Psoriasis; QUALITY-OF-LIFE; SEVERITY; MODERATE; DISEASE; VALIDATION; MANAGEMENT; ARTHRITIS; THERAPY; BURDEN; SCALE;
D O I
10.1590/abd1806-4841.20153736
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND: Psoriasis is a disease of worldwide distribution with a prevalence of 1 to 3%. Nail psoriasis is estimated in 50% of patients with psoriasis, and in the presence of joint involvement, it can reach 80%. OBJECTIVE: To study the nail changes - and their clinical implications - presented by patients with psoriasis vulgaris under surveillance in a university hospital from the south of Brazil. METHODS: This cross-sectional study evaluated 65 adult patients from January 2012 to March 2013. Cutaneous severity was assessed according to the Psoriasis Area and Severity Index (PASI). The Nail Psoriasis Severity Index (NAPSI) was used to evaluate patient's nails. The diagnosis of psoriatic arthritis was established according to the Classification Criteria for Psoriatic Arthritis (CASPAR). RESULTS: The prevalence of NP was 46.1%. These patients had a median [interquartilic range (IQR)] NAPSI of 1 (015). A total of 63.3% of patients reported aesthetic discomfort or functional impairment related to their nails. Onycholysis was the most common feature (80%). When compared with patients without nail involvement, patients with NP had lower mean age at psoriasis onset [21 (18-41) vs. 43 (30-56) years, p=0,001]; longer disease duration [15.5 (10-24) vs. 6 (2-12) years, p=0.001]; higher PASI [9.2 (5-17) vs. 3.7 (2-10), p=0.044], higher frequency of psoriatic arthritis (43.3 vs. 3.7, p=0.002) and more often reported family history of psoriasis (40% vs. 7.4%, p=0.011). CONCLUSION: Onycholysis was the most frequent finding and most patients feel uncomfortable with the psoriatic nail changes that they experience.
引用
收藏
页码:314 / 319
页数:6
相关论文
共 50 条
  • [31] Comparative Tolerability of Systemic Treatments for Plaque-Type Psoriasis
    Stacy L. McClure
    Jayme Valentine
    Kenneth B. Gordon
    Drug Safety, 2002, 25 : 913 - 927
  • [32] Infliximab monotherapy in the treatment of plaque-type psoriasis.
    Gottlieb, AB
    Chaudhari, U
    Romano, P
    Mulcahy, LD
    Dooley, LT
    Baker, DG
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S383 - S383
  • [33] Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis
    Saraceno, Rosita
    Bavetta, Mauro
    Zangrilli, Arianna
    Chiricozzi, Andrea
    Potenza, Concetta
    Chimenti, Sergio
    Chimenti, Maria Sole
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1325 - 1334
  • [34] Comparative tolerability of systemic treatments for plaque-type psoriasis
    McClure, SL
    Valentine, J
    Gordon, KB
    DRUG SAFETY, 2002, 25 (13) : 913 - 927
  • [35] Calcipotriene foam is an effective treatment for plaque-type psoriasis
    Feldman, Steve
    Li, George
    Wyres, Melody
    Van Syoc, Merrie
    Kempers, Steve
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB146 - AB146
  • [36] The effect of weight loss in obese patients with chronic stable plaque-type psoriasis
    Roongpisuthipong, Wanjarus
    Roongpisuthipong, Chulaporn
    Pongpudpunth, Marinya
    Rajatanavin, Natta
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB4 - AB4
  • [37] Increased intestinal barrier permeability in patients with moderate to severe plaque-type psoriasis
    Richetta, Antonio Giovanni
    Grassi, Sara
    Moliterni, Elisa
    Chello, Camilla
    Calvieri, Camilla
    Carnevale, Roberto
    Peruzzi, Mariangela
    Violi, Francesco
    Calvieri, Stefano
    JOURNAL OF DERMATOLOGY, 2020, 47 (10): : E366 - E368
  • [38] The Effect of Weight Loss in Obese Patients with Chronic Stable Plaque-Type Psoriasis
    Roongpisuthipong, Wanjarus
    Pongpudpunth, Marinya
    Roongpisuthipong, Chulaporn
    Rajatanavin, Natta
    DERMATOLOGY RESEARCH AND PRACTICE, 2013, 2013
  • [39] Pharmacokinetics and pharmacodynamics of infliximab in a phase III trial in patients with plaque-type psoriasis
    Zhu, Y
    Menter, A
    Jang, H
    Zhou, H
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB222 - AB222
  • [40] Overall Prevalence and Prevalence Compared among Psoriasis Treatments of Onychomycosis in Patients with Nail Psoriasis and Fungal Involvement
    Chularojanamontri, Leena
    Pattanaprichakul, Penvadee
    Leeyaphan, Charussri
    Suphatsathienkul, Panittra
    Wongdama, Supisara
    Bunyaratavej, Sumanas
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021